aua

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed…

2 weeks ago

BugleRock Capital’s Global AUA Surpasses $4 Billion USD

 Launches Fixed Income Advisory Services with Expert Team BENGALURU, India, July 8, 2025 /PRNewswire/ -- BugleRock Capital, a leading global…

11 months ago